Involvement of the N-methyl-d-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity

Molecular Brain

Volumn 6, Issue 1, 2013, Pages

  Yamamoto, Hideko ^a   Kamegaya, Etsuko ^a   Sawada, Wakako ^a,b   Hasegawa, Ryota ^a,b   Yamamoto, Toshifumi ^a,b   Hagino, Yoko ^a   Takamatsu, Yukio ^a   Imai, Kazuhide ^c   Koga, Hisashi ^c   Mishina, Masayoshi ^d   Ikeda, Kazutaka ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^d RITSUMEIKAN UNIVERSITY   (Japan)

Author keywords

GluN2C; GluN2D; Motor impairment; Motor loop; PCP

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2C; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; PROTEIN FOS; UBP 141; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN; BRAIN REGION; BRAIN STEM; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; FEMALE; GENE EXPRESSION; GLOBUS PALLIDUS; IMMUNOREACTIVITY; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; THALAMUS;

ANIMALIA; MUS;

ANIMALS; BRAIN; COMPUTATIONAL BIOLOGY; DANTROLENE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENCYCLIDINE; PROTEIN SUBUNITS; PROTO-ONCOGENE PROTEINS C-FOS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, N-METHYL-D-ASPARTATE; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; STRESS, PHYSIOLOGICAL;

EID: 84890300248     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-6-56     Document Type: Article

References (39)

1. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Watanabe M, Inoue Y, Sakimura K, Mishina M, Neuroreport 1992 3 1138 1140 10.1097/00001756-199212000-00027 1493227 (Pubitemid 23034721)
2. Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel. Ikeda K, Araki K, Takayama C, Inoue Y, Yagi T, Aizawa S, Mishina M, Brain Res Mol Brain Res 1995 33 61 71 10.1016/0169-328X(95) 00107-4 8774946
3. Lower sensitivity to stress and altered monoaminergic neuronal function in mice lacking the NMDA receptor epsilon 4 subunit. Miyamoto Y, Yamada K, Noda Y, Mori H, Mishina M, Nabeshima T, J Neurosci 2002 22 2335 2342 11896172 (Pubitemid 35386532)
4. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Selemon LD, Goldman-Rakic PS, Biol Psychiatry 1999 45 17 25 10.1016/S0006- 3223(98)00281-9 9894571 (Pubitemid 29049200)
5. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R, Psychopharmacology (Berl) 2003 169 215 233 10.1007/s00213-003-1582-z 12955285 (Pubitemid 37264943)
6. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Geyer M, Krebs-Thomson K, Braff D, Swerdlow N, Psychopharmacology (Berlin) 2001 156 117 154 10.1007/s002130100811 (Pubitemid 32702206)
7. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. Carlsson M, Carlsson A, J Neural Transm 1989 75 221 226 10.1007/BF01258633 2538557 (Pubitemid 19039948)
8. Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine. Lindahl JS, Keifer J, Neuropsychopharmacology 2004 29 2065 2073 10.1038/sj.npp.1300485 15138442 (Pubitemid 39486558)
9. Essential role of NMDA receptor channel epsilon4 subunit (GluN2D) in the effects of phencyclidine, but not methamphetamine. Hagino Y, Kasai S, Han W, Yamamoto H, Nabeshima T, Mishina M, Ikeda K, PLoS One 2010 5 13722 10.1371/journal.pone.0013722 21060893
10. Franklin K, Paxinos G, The Mouse Brain in Stereotaxic Coordinates Amsterdam: Academic Press/Elsevier 3 2007
11. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. Kobayashi S, Yano M, Suetomi T, Ono M, Tateishi H, Mochizuki M, Xu X, Uchinoumi H, Okuda S, Yamamoto T, et al. J Am Coll Cardiol 2009 53 1993 2005 10.1016/j.jacc.2009.01.065 19460614
12. Glutamate receptor ion channels: structure, regulation, and function. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R, Pharmacol Rev 2010 62 405 496 10.1124/pr.109.002451 20716669
13. Vglut2 haploinsufficiency enhances behavioral sensitivity to MK-801 and amphetamine in mice. Naert A, Callaerts-Vegh Z, Moechars D, Meert T, D'Hooge R, Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 1316 1321 10.1016/j.pnpbp.2011.03.023
14. N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. Costa B, Feng B, Tsintsadze T, Morley R, Irvine M, Tsintsadze V, Lozovaya N, Jane D, Monaghan D, J Pharmacol Exp Ther 2009 331 618 626 10.1124/jpet.109.156752 19684252
15. A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors. Mullasseril P, Hansen KB, Vance KM, Ogden KK, Yuan H, Kurtkaya NL, Santangelo R, Orr AG, Le P, Vellano KM, Liotta DC, Traynelis SF, Nat Commun 2010 1 90 20981015
16. Translational principles of deep brain stimulation. Kringelbach ML, Jenkinson N, Owen SL, Aziz TZ, Nat Rev Neurosci 2007 8 623 635 10.1038/nrn2196 17637800 (Pubitemid 47093935)
17. Excitotoxic acid lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs. Hamada I, DeLong MR, J Neurophysiol 1992 68 1850 1858 1479448
18. In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit. Baunez C, Nieoullon A, Amalric M, J Neurosci 1995 15 6531 6541 7472415
19. Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus. Baunez C, Amalric M, Robbins TW, J Neurosci 2002 22 562 568 11784803 (Pubitemid 34049096)
20. Bilateral lesions of the subthalamic nucleus induce multiple deficits in an attentional task in rats. Baunez C, Robbins TW, Eur J Neurosci 1997 9 2086 2099 10.1111/j.1460-9568.1997.tb01376.x 9421169 (Pubitemid 27485241)
21. Postural and anticonvulsant effects of inhibition of the rat subthalamic nucleus. Dybdal D, Gale K, J Neurosci 2000 20 6728 6733 10964979
22. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Alexander GE, Crutcher MD, Trends Neurosci 1990 13 266 271 10.1016/0166-2236(90)90107-L 1695401 (Pubitemid 20193456)
23. Primate models of movement disorders of basal ganglia origin. DeLong MR, Trends Neurosci 1990 13 281 285 10.1016/0166-2236(90)90110-V 1695404
24. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Parent A, Hazrati LN, Brain Res Brain Res Rev 1995 20 128 154 10.1016/0165-0173(94)00008-D 7711765
25. Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. Standaert DG, Testa CM, Young AB, Penney JB Jr, J Comp Neurol 1994 343 1 16 10.1002/cne.903430102 8027428 (Pubitemid 24129523)
26. Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats. Amitai N, Kuczenski R, Behrens MM, Markou A, Neuropharmacology 2012 62 1422 1431 10.1016/j.neuropharm. 2011.01.008 21238466
27. Topographical projections of the cerebral cortex to the subthalamic nucleus. Afsharpour S, J Comp Neurol 1985 236 14 28 10.1002/cne.902360103 2414329 (Pubitemid 15042841)
28. Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Canteras NS, Shammah-Lagnado SJ, Silva BA, Ricardo JA, Brain Res 1990 513 43 59 10.1016/0006-8993(90)91087-W 2350684 (Pubitemid 20144271)
29. The glutamate-enriched cortical and thalamic input to neurons in the subthalamic nucleus of the rat: convergence with GABA-positive terminals. Bevan MD, Francis CM, Bolam JP, J Comp Neurol 1995 361 491 511 10.1002/cne.903610312 8550895
30. The early response gene NGFI-C encodes a zinc finger transcriptional activator and is a member of the GCGGGGGCG (GSG) element-binding protein family. Crosby S, Puetz J, Simburger K, Fahrner T, Milbrandt J, Mol Cell Biol 1991 11 3835 3841 2072895 (Pubitemid 21895771)
31. Neural-specific expression, genomic structure, and chromosomal localization of the gene encoding the zinc-finger transcription factor NGFI-C. Crosby S, Veile R, Donis-Keller H, Baraban J, Bhat R, Simburger K, Milbrandt J, Proc Natl Acad Sci U S A 1992 89 4739 4743 10.1073/pnas.89.10.4739 1584812
32. Prolonged expression of zinc finger immediate-early gene mRNAs and decreased protein synthesis following kainic acid induced seizures. Honkaniemi J, Sharp F, Eur J Neurosci 1999 11 10 17 10.1046/j.1460-9568.1999.00401.x 9987007 (Pubitemid 29012307)
33. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, Minda K, Oliner JD, McKeon F, Haber DA, Mol Cell 2002 10 995 1005 10.1016/S1097-2765(02)00706-2 12453409 (Pubitemid 35453821)
34. TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1. Jin HO, Seo SK, Kim YS, Woo SH, Lee KH, Yi JY, Lee SJ, Choe TB, Lee JH, An S, et al. Oncogene 2011 30 3792 3801 10.1038/onc.2011.102 21460850
35. Chaperone-assisted selective autophagy is essential for muscle maintenance. Arndt V, Dick N, Tawo R, Dreiseidler M, Wenzel D, Hesse M, Furst DO, Saftig P, Saint R, Fleischmann BK, et al. Curr Biol 2010 20 143 148 10.1016/j.cub.2009.11.022 20060297
36. The co-chaperone CHIP is induced in various stresses and confers protection to cells. Dikshit P, Jana NR, Biochem Biophys Res Commun 2007 357 761 765 10.1016/j.bbrc.2007.04.018 17442270 (Pubitemid 46653846)
37. HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. Jacobs AT, Marnett LJ, J Biol Chem 2009 284 9176 9183 10.1074/jbc.M808656200 19179333
38. Methamphetamine modulation of gene expression in the brain: analysis using customized cDNA microarray system with the mouse homologues of KIAA genes. Yamamoto H, Imai K, Takamatsu Y, Kamegaya E, Kishida M, Hagino Y, Hara Y, Shimada K, Yamamoto T, Sora I, et al. Brain Res Mol Brain Res 2005 137 40 46 10.1016/j.molbrainres.2005.02.028 15950759 (Pubitemid 40798884)
39. Abnormal gene expression in cerebellum of Npc1-/- mice during postnatal development. Liao G, Wen Z, Irizarry K, Huang Y, Mitsouras K, Darmani M, Leon T, Shi L, Bi X, Brain Res 2010 1325 128 140 20153740 Technology Technology Technology